Twitter feed
Follow us
The new Pricing System in Russia will lead to price decreases for many medicines - https://t.co/uOTiv4G5qT
Renting a lifetime therapy vs. Buying a ‘one-off’ – Has the high price tag historically hindered reimbursement? - https://t.co/fn1yw4QwPb
Analytics and Forecasting for efficient business development, early pricing and target product profile optimisation. - https://t.co/JaMsARTqkd
Prices of Pfizer's leukaemia drug Bosulif cut by 13% in Germany after HTA - https://t.co/Dmwal4RyuX
New set of rules regulating medicine prices in Kazakhstan - https://t.co/6TMLmw7etl
Malaysian authorities approve the introduction of IRP - https://t.co/aZNjtkvNbc
New IRP rule introduced in Greece - https://t.co/R4DxeKoZO7
Harmonisation of HTA practice: Underlying methodological differences across HTA agencies that impact national list prices - https://t.co/Tczhkp1sUs
Employee Spotlight - Shivani Shah - https://t.co/dxTC8mOewV
Employee Spotlight - Madhuri Chhatbar - https://t.co/wQvdpCkKPt
Employee Spotlight - Pramod Mali - https://t.co/hDVRbXzpIz
Pricing pharmaceuticals: The transition from prospective qualitative research to predictive data analytics - https://t.co/UIRe7jJgXn
Employee Spotlight - Popat Bankar - https://t.co/RvAMPV93XV
Employee Spotlight - Tom Brockbank - https://t.co/RKKFjmzqfi
Employee Spotlight - https://t.co/UQRHlPqHK7
GPI are Hiring! - https://t.co/N4juMSDQrS
Combination therapy for melanoma: What are the current challenges in pricing & access from EU and US payers’ perspective? https://t.co/W8dHEA1tNu
Taking stock: European cross-border cooperation on medicines’ value-assessment, and Pricing & Reimbursement negotiations via @PricingGlobal
Taking stock: European cross-border cooperation on medicines’ value-assessment, and Pricing & Reimbursement negotiations
Fertile ground for cross-border cooperation Even with pan-European EMA approval, pricing is still a country-level issue, with national governments, re...
globalpricinginnovations.wordpress.com
Taking stock: European cross-border cooperation on medicines’ value-assessment, and Pricing & Reimbursement negotiations https://t.co/Ar1IA9H3ss
Learn – Engage – Apply – Perform! GPI has launched LEAP; our new career development & training programme https://t.co/zn3nhxrvHU
Pricing policy: Germany – a court ruling as soon as June could set a new tone for AMNOG pricing… but is access becoming a more complex moving target for industry? https://t.co/6WoHxLdRVR
Need a new approach to your pricing strategies? Watch GPI’s video to learn more about our innovative methodologies…
Need a new approach to your pricing strategies? Watch GPI’s video to learn more about our innovative methodologies…
Video post by @PricingGlobal.
globalpricinginnovations.wordpress.com
Thanks for a great Day 1. The GPI team looks forward to doing it all again today! #PPMA @globalpricing
The GPI team looks forward to meeting all delegates at PPMA in London next week (# Stand 31). We are running a short GPI PPMA Challenge Quiz for congress delegates. Go on to the PPMA EU 2018 Congress App for details. #PPMA
What will shape the global pharmaceutical pricing environment in 2018? https://t.co/9vyE96EBgI
Spark's planned price for Luxturna gene therapy for rare blindness too high: ICER
https://t.co/0DEsm7LGXc
Gene therapy for 'bubble baby' syndrome approved on NHS
Gene therapy for 'bubble baby' syndrome approved on NHS
GlaxoSmithKline’s Strimvelis is the first such treatment to be funded in the UK
lnkd.in
Season’s Greetings from GPI https://t.co/Ig1Ro3kSwl
The new Pricing System in Russia will lead to price decreases for many medicines - https://t.co/uOTiv4G5qT
Renting a lifetime therapy vs. Buying a ‘one-off’ – Has the high price tag historically hindered reimbursement? - https://t.co/fn1yw4QwPb
Analytics and Forecasting for efficient business development, early pricing and target product profile optimisation. - https://t.co/JaMsARTqkd
Prices of Pfizer's leukaemia drug Bosulif cut by 13% in Germany after HTA - https://t.co/Dmwal4RyuX
New set of rules regulating medicine prices in Kazakhstan - https://t.co/6TMLmw7etl
Malaysian authorities approve the introduction of IRP - https://t.co/aZNjtkvNbc
New IRP rule introduced in Greece - https://t.co/R4DxeKoZO7
Harmonisation of HTA practice: Underlying methodological differences across HTA agencies that impact national list prices - https://t.co/Tczhkp1sUs
Employee Spotlight - Shivani Shah - https://t.co/dxTC8mOewV
Employee Spotlight - Madhuri Chhatbar - https://t.co/wQvdpCkKPt
Employee Spotlight - Pramod Mali - https://t.co/hDVRbXzpIz
Pricing pharmaceuticals: The transition from prospective qualitative research to predictive data analytics - https://t.co/UIRe7jJgXn
Employee Spotlight - Popat Bankar - https://t.co/RvAMPV93XV
Employee Spotlight - Tom Brockbank - https://t.co/RKKFjmzqfi
Employee Spotlight - https://t.co/UQRHlPqHK7
GPI are Hiring! - https://t.co/N4juMSDQrS
Combination therapy for melanoma: What are the current challenges in pricing & access from EU and US payers’ perspective? https://t.co/W8dHEA1tNu
Taking stock: European cross-border cooperation on medicines’ value-assessment, and Pricing & Reimbursement negotiations via @PricingGlobal
Taking stock: European cross-border cooperation on medicines’ value-assessment, and Pricing & Reimbursement negotiations
Fertile ground for cross-border cooperation Even with pan-European EMA approval, pricing is still a country-level issue, with national governments, re...
globalpricinginnovations.wordpress.com
Taking stock: European cross-border cooperation on medicines’ value-assessment, and Pricing & Reimbursement negotiations https://t.co/Ar1IA9H3ss
Learn – Engage – Apply – Perform! GPI has launched LEAP; our new career development & training programme https://t.co/zn3nhxrvHU
Pricing policy: Germany – a court ruling as soon as June could set a new tone for AMNOG pricing… but is access becoming a more complex moving target for industry? https://t.co/6WoHxLdRVR
Need a new approach to your pricing strategies? Watch GPI’s video to learn more about our innovative methodologies…
Need a new approach to your pricing strategies? Watch GPI’s video to learn more about our innovative methodologies…
Video post by @PricingGlobal.
globalpricinginnovations.wordpress.com
Thanks for a great Day 1. The GPI team looks forward to doing it all again today! #PPMA @globalpricing
The GPI team looks forward to meeting all delegates at PPMA in London next week (# Stand 31). We are running a short GPI PPMA Challenge Quiz for congress delegates. Go on to the PPMA EU 2018 Congress App for details. #PPMA
What will shape the global pharmaceutical pricing environment in 2018? https://t.co/9vyE96EBgI
Spark's planned price for Luxturna gene therapy for rare blindness too high: ICER
https://t.co/0DEsm7LGXc
Gene therapy for 'bubble baby' syndrome approved on NHS
Gene therapy for 'bubble baby' syndrome approved on NHS
GlaxoSmithKline’s Strimvelis is the first such treatment to be funded in the UK
lnkd.in
Season’s Greetings from GPI https://t.co/Ig1Ro3kSwl
